Michael I. Webb, Ph.D.
Affiliations: | Simon Fraser University, Burnaby, British Columbia, Canada |
Area:
Bioinorganic chemistry, spectroscopyGoogle:
"Michael Webb"Mean distance: 9.19 | S | N | B | C | P |
Parents
Sign in to add mentor| Charles J. Walsby | grad student | 2013 | Simon Fraser | |
| (Spectroscopic Studies of the Physiological Speciation of Ruthenium(III) Anticancer Complexes.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Ehlbeck JT, Grimard DM, Hacker RM, et al. (2023) Finding the best location: Improving the anti-amyloid ability of ruthenium(III) complexes with pyridine ligands. Journal of Inorganic Biochemistry. 250: 112424 |
| Wall BJ, Will MF, Yawson GK, et al. (2021) Importance of Hydrogen Bonding: Structure-Activity Relationships of Ruthenium(III) Complexes with Pyridine-Based Ligands for Alzheimer's Disease Therapy. Journal of Medicinal Chemistry |
| Yawson GK, Huffman SE, Fisher SS, et al. (2020) Ruthenium(III) complexes with imidazole ligands that modulate the aggregation of the amyloid-β peptide via hydrophobic interactions. Journal of Inorganic Biochemistry. 214: 111303 |
| Huffman SE, Yawson GK, Fisher SS, et al. (2020) Ruthenium(iii) complexes containing thiazole-based ligands that modulate amyloid-β aggregation. Metallomics : Integrated Biometal Science |
| Safaei E, Balaghi SE, Chiang L, et al. (2019) Stabilization of different redox levels of a tridentate benzoxazole amidophenoxide ligand when bound to Co(iii) or V(v). Dalton Transactions (Cambridge, England : 2003) |
| Webb MI, Walsby CJ. (2015) Albumin binding and ligand-exchange processes of the Ru(iii) anticancer agent NAMI-A and its bis-DMSO analogue determined by ENDOR spectroscopy. Dalton Transactions (Cambridge, England : 2003) |
| Jones MR, Mu C, Wang MC, et al. (2015) Modulation of the Aβ peptide aggregation pathway by KP1019 limits Aβ-associated neurotoxicity. Metallomics : Integrated Biometal Science. 7: 129-35 |
| Lo SY, Säbel CE, Webb MI, et al. (2014) High metal substitution tolerance of anthrax lethal factor and characterization of its active copper-substituted analogue. Journal of Inorganic Biochemistry. 140: 12-22 |
| Webb MI, Wu B, Jang T, et al. (2013) Increasing the bioavailability of Ru(III) anticancer complexes through hydrophobic albumin interactions. Chemistry (Weinheim An Der Bergstrasse, Germany). 19: 17031-42 |
| Webb MI, Walsby CJ. (2013) EPR as a probe of the intracellular speciation of ruthenium(III) anticancer compounds. Metallomics : Integrated Biometal Science. 5: 1624-33 |